Press Releases Latest Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates Press Releases Year None20232022202120202019201820172016201520142013 Jun 10, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers May 31, 2021 Theratechnologies Hires Vice President, Human Resources May 20, 2021 Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo® May 18, 2021 Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021 May 13, 2021 Announcements in Conjunction With Theratechnologies Annual Meeting Apr 14, 2021 Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights Apr 12, 2021 Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference Apr 01, 2021 Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021 Apr 10, 2021 Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types Mar 29, 2021 Theratechnologies Announces Two Strategic Hires to Support its Commercial and Pipeline Assets First page « Previous page ‹ … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page › Last page » Displaying 81 - 90 of 328
Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
Jun 10, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers
May 20, 2021 Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo®
May 18, 2021 Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021
Apr 14, 2021 Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
Apr 10, 2021 Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types
Mar 29, 2021 Theratechnologies Announces Two Strategic Hires to Support its Commercial and Pipeline Assets
